Rush University Medical Center-Hematology and Oncology ( Site 0028)

Chicago, Illinois 60607

1 studies enrolling now · 1 studies all time

What they study most

Prostate Cancer, Prostatic Neoplasms

Studies at this site

• A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) — Recruiting now